English - Global Alliance to Eliminate Lymphatic Filariasis

More documents

Recommendations

Info

REPORT OF THE 6 TH GAELF MEETING, JUNE 2010 Half-time Score in Morbidity Control Impact of MDA on Clinical Disease .......................................................................................... 27 Prevention of Lymphoedema in Children ................................................................................ 27 Integrated Morbidity Control: LF, Leprosy, and Diabetes Footcare ........................................ 28 Hydrocele Surgery .................................................................................................................... 29 Economic and Psychosocial Impact of Hydrocele and the Benefits of Hydrocelectomy ........ 29 Integrative Self-care Through Community Participation for Morbidity Management ........... 30 Half-time Strategy: Future Research and Application Strategies for the End Game: Operational Research Update .................................................. 31 Diagnostics: Development of Applicable Tools ....................................................................... 31 Role of Vector Sampling – Xenodiagnosis in Post-MDA Surveillance ...................................... 32 Post-treatment Surveillance for LF: Togo Case Description .................................................... 32 LF and NTDs – The Chicken or the Egg: How do we Stop MDA? ............................................. 33 Half-time Strategy: Major Technical Challenges LF in the City – The Urban Problem ......................................................................................... 35 LF in the Forest ......................................................................................................................... 36 LF in Conflict Zones .................................................................................................................. 36 LF after MDA ............................................................................................................................ 37 Half-time Strategy: Alternative Strategies for the Second Half Filariasis Chemotherapy for the Next Decade ......................................................................... 38 Role of Antibiotics Against Wolbachia: Can it Play a Role in the Endgame? ........................... 38 Role of Vector Control ............................................................................................................. 39 Second Half 2010-2020: Strategy for the Next Decade The Vision Moving Forward ..................................................................................................... 40 Building Partnerships for Morbidity Control ........................................................................... 41 Building Partnerships for Implementation .............................................................................. 41 Developing the Operational Research Agenda ........................................................................ 42 Resourcing the strategy African Development Bank ...................................................................................................... 43 USAID NTD Strategy 2010-2014 ............................................................................................... 43 World Bank............................................................................................................................... 44 Alternative Resource Strategies for NTDs ............................................................................... 44 6
REPORT OF THE 6 TH GAELF MEETING, JUNE 2010 Future of the GAELF Partnership NGDO Linkages Between LF and Other NTD Groups ............................................................... 46 Opportunities: Advocacy and Broader Partnerships in the Evolving Global Health Environment............................................................................................................................. 46 Conclusions and Reflections .................................................................................................... 47 Closing Ceremony .................................................................................................................... 47 Business Session of the Representative Contact Group ................................................... 49 Special Session: Enhancing Disability Prevention Implementation Through Partnerships . 50 References ..................................................................................................................... 52 List of Participants .......................................................................................................... 54 7
Page 1 and 2: Half-time in LF Elimination: Teamin
Page 3 and 4: REPORT OF THE 6 TH GAELF MEETING, J
Page 5: REPORT OF THE 6 TH GAELF MEETING, J
Page 57 and 58:
REPORT OF THE 6 TH GAELF MEETING, J
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69:
show all

English - Global Alliance to Eliminate Lymphatic Filariasis

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?